Jump to content
MycoMap Beta
Sign in to follow this  
  • entries
    7,766
  • comments
    0
  • views
    6,114

SCYNEXIS says Phase 3 program underway for treatment of acute yeast infection - Proactive Investors USA & Canada

Sign in to follow this  
MycoMap

4 views

SCYNEXIS says Phase 3 program underway for treatment of acute yeast infection  Proactive Investors USA & Canada

SCYNEXIS, Inc. (NASDAQ:SCYX) - The biotech expects top-line data on the use of oral ibrexafungerp for acute vulvovaginal candidiasis (VVC) in the first half of ...


View the full article

Sign in to follow this  

×